Email from Mick Behan, APPGITA Researcher, to Anne Milton MP
May 17, 2012
Thank you for your email concerning the APPGITA circulation list. Jim Dobbin MP, chair of the APPGITA has asked me to provide you with the following response:
Due to the exclusion of APPGITA from the Roundtable and the excessive secrecy constructed by the Department of Health around that group we believe members have not had the opportunity to consider an alternative viewpoint to that presented by the Department. For that reason we circulated Professor Ashton’s important comments on the consensus statement. The feedback we have have had so far from that circulation has been 100% positive and supportive. We believe it is important that Roundtable members continue to receive alternative information on involuntary tranquilliser addiction and APPGITA therefore intends to continue to use this circulation list. Any Roundtable members who do not want to receive APPGITA information should notify me and they will be immediately removed from the circulation list.
Researcher for Jim Dobbin MP
Chair, All Party Parliamentary Group on Involuntary Tranquilliser Addiction
Email from Anne Milton MP to Mick Behan, APPGITA
(ccd by Anne Milton to all interested parties including benzo.org.uk)
May 16, 2012
Thank you for sight of Professor Ashton’s comments on the draft consensus statement.
However, I understand that some members of the roundtable have expressed concern and distress that information, including private email addresses of service users have been made available to individuals outside of the roundtable.
I am sure that you realise the sensitivities of using personal details and so I would be most grateful if you could refrain from using the private distribution list of the roundtable in any future correspondence. Please let me know if I can help further on this issue. I am sure I needn’t reiterate what concern this has caused.
Thank you for your help with this.
Private Office of Anne Milton MP
Parliamentary Under Secretary of State for Public Health Department of Health
020 7 210 5115
Please respond to email@example.com